VOYA INVESTMENT MANAGEMENT LLC
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 1068837
ATLANTA, GA
Position in ORIC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$160,565
+$18,383 QoQ
Shares Held
14,826
+32.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 179 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. ORIC ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in ORIC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,565 | 14,826 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $142,182 | 11,222 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $89,440 | 10,934 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $129,189 | 12,728 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $94,218 | 16,885 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $151,627 | 18,789 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $211,098 | 20,595 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $150,202 | 21,245 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $179,148 | 13,029 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $151,404 | 16,457 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $96,382 | 15,931 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $123,624 | 15,931 | Shares | Defined | 2025-02-07 | |
| 2022-03-31 | $63,839 | 11,955 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $987,735 | 67,193 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,837,234 | 183,512 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,707,471 | 153,051 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,461,784 | 100,481 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,290,016 | 97,194 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||